Intocell

KOSDAQ · Healthcare · ₩252B

₩15,930-1.06%

Price

19,750원

15,830원

Jul 24, 26Oct 27, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

6/'26

Revenue₩760M+170.4%

Operating Income-₩2.2B+37.5%

Net Income-₩2.1B+48.3%

3/'26 vs prev quarter

Company Health

Market Cap₩252B

Operating Margin-279.0%

Cash on Hand106억원4.2% of market cap

Free Cash Flow-118억원-4.7% of market cap

Short Volume 3.3% · as of 26.10.27

Among 37 신약 개발 peers

LowMedianHigh

PSR78.5xmedian 23.7xPBR12.7xmedian 5.2xROE-48.0%median -34.9%